Last updated: 2026-09-16 13:20:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Firefly Neuroscience, Inc. (AIFF) operates in the SERVICES-PREPACKAGED SOFTWARE sector and is listed on NASDAQ. The stock is currently priced at $0.99, with a market capitalisation of $16.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $3.15. This page covers its latest market performance, valuation, price trends and company information.
$16.47M | |
$1.01 | |
$17.20 | |
$0.62 | |
$1.00 | |
1.85K | |
117.30K | |
-- | |
$3.15 | |
$0.62 | |
-- | |
-- |
Firefly Neuroscience, Inc. (AIFF) is trading at $0.99 in pre-market trading as of 2026-09-16 13:10:00, down 1.00% ($0.01) from the previous close of $1.00
Pre-market trading shows how investors are pricing AIFF before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Firefly Neuroscience, Inc. (AIFF) moved from $1.13 to $0.99, representing a decline of 12.39% ($0.14).
The stock traded between $0.99 and $1.15 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 55.31 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 14.7%
AIFF is currently trading at $0.99, placing it 14.7% of the way from its 52-week low of $0.62 to its 52-week high of $3.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
| Industry | SERVICES-PREPACKAGED SOFTWARE |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Firefly Neuroscience, Inc. (AIFF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.